Register Login
Register to leave comments
  • News bot March 26, 2026, 11:11 a.m.

    📋 MAPLIGHT THERAPEUTICS, INC. (MPLT) - Financial Results

    Filing Date: 2026-03-26

    Accepted: 2026-03-26 07:10:11

    Event Type: Financial Results

    Event Details:

    MAPLIGHT THERAPEUTICS, INC. (MPLT) Reports the reporting period Financial Results MAPLIGHT THERAPEUTICS, INC. (MPLT) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 453096
      • expected in the third quarter of 2026
      • expected in 2026
      • targeting those circuits for therapeutic modulation. For more information, please visit www.maplightrx.com. Forward Looking StatementsCertain statements in this press release may constitute “forward-looking statements” within the meaning of the federal securities laws, including, but not limited to, the Company’s expectations regarding plans for and potential benefits of its current and future product candidates and programs, plans for its current and future clinical trials, plans for clinical trial design, the anticipated timing of the initiation of, enrollment in and results from the Company’s clinical trials, the timing of candidate selection in the ML-055 program, the potential once-daily dosing and a long-acting injectable formulation of ML-055 and the sufficiency of the Company’s cash, cash equivalents and investments to fund its operations through 2027

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Operating Expenses Loss From Operations 22.78K 169.08K $-146.31K -86.53%
    Other Income Expense Net Interest Income 899.00 5.52K $-4.62K -83.71%
    Loss From Equity Method Investment Other Income Net 650.00 2.41K $-1.76K -73.06%
    Loss From Equity Method Investment Net Loss 21.23K 161.15K $-139.92K -86.83%
    Loss From Equity Method Investment Net Loss Per Share 27.95 18.56 $9.39 +50.59%
    Loss from Operations 83.38K 22.78K $60.60K +266.05%
    Interest Income 2.47K 899.00 $1.57K +174.86%
    Other Income, Net 1.36K 650.00 $709.00 +109.08%
    Net Loss 79.55K 21.23K $58.32K +274.71%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: MAPLIGHT THERAPEUTICS, INC.
    • Ticker Symbol: MPLT

Search

News categories